Background and Objectives: The mechanism for the destruction of a patient's own platelets in post–transfusion purpura (PTP) is unknown. In order to test the hypothesis that the destruction of autologous platelets in PTP is related to the presence of platelet antibodies with pan–reactivity, we investigated sera from patients with PTP. Materials and Methods: Sera from 12 patients with PTP were investigated for platelet antibodies by platelet–ELISA and monoclonal antibody–specific immobilization of platelet antigen assay. Results: During the thrombocytopenic phase, antibodies of IgG and IgM classes with pan–specificity against platelet GPIIb–IIIa, GPIb–IX and GPIa–IIa were found together with HPA alloantibodies. After recovery, the pan–specific antibodies disappeared or the extent of reactivity diminished, whereas the IgG HPA alloantibodies persisted. Conclusion: These findings provide evidence that transient panreactive antibodies may be responsible for the autologous platelet destruction in PTP.
Received: Received: July 8, 1997
Revised manuscript received: April 10, 1998
Accepted: August 5, 1998
Number of Print Pages : 4
Number of Figures : 1, Number of Tables : 1, Number of References : 11
Vox Sanguinis (International Journal of Transfusion Medicine)
Founded 1956 (formerly Bulletin of the Central Laboratory of the NRC Blood Transfusion Service, founded 1951)
Official Journal of the International Society of Blood Transfusion. Published in cooperation with the League of Red Cross Societies, Geneva
Vol. 76, No. 2, Year 1999 (Cover Date: Released March 1999)
Journal Editor: M. Contreras, London
ISSN: 0042–9007 (print), 1423–0410 (Online)
For additional information: http://www.karger.com/journals/vox
Article / Publication Details
Published online: 3/19/1999
Issue release date: March 1999
Number of Print Pages: 4
Number of Figures: 1
Number of Tables: 1
ISSN: 0042-9007 (Print)
eISSN: 1423-0410 (Online)
For additional information: http://www.karger.com/VOX
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.